The Development of Enzyme-Activated Prochelators Designed to Target Cancer Cells Overexpressing γ-glutamyltransferase
Date
2017
Authors
Advisors
Journal Title
Journal ISSN
Volume Title
Abstract
Millions of people around the world eventually develop or currently suffer from some form of cancer. According to the American Cancer Society, 1.6 million new cases of cancer were predicted in the United States alone.One of the main reasons for this high mortality rate is that cancer can be an exceedingly difficult disease to treat. In response to the need for better drugs, enzymatically-activated Cu prochelators (GluBro and GluTCarb) have been developed to specifically target cancer cells and create cytotoxic complexes within tumor tissue. The experiments performed herein suggest both GluBro and GluTCarb demonstrate cancer selective cellular activity dependent on the presence of Cu and the enzyme gamma-glutamyltransferase
Type
Department
Description
Provenance
Citation
Permalink
Citation
Sleeper, Mark (2017). The Development of Enzyme-Activated Prochelators Designed to Target Cancer Cells Overexpressing γ-glutamyltransferase. Dissertation, Duke University. Retrieved from https://hdl.handle.net/10161/14555.
Collections
Except where otherwise noted, student scholarship that was shared on DukeSpace after 2009 is made available to the public under a Creative Commons Attribution / Non-commercial / No derivatives (CC-BY-NC-ND) license. All rights in student work shared on DukeSpace before 2009 remain with the author and/or their designee, whose permission may be required for reuse.